Brief: Cogent Biosciences Appoints Cole Pinnow As Chief Commercial Officer
23/05/2024 23:56
May 23 (Reuters) - Cogent Biosciences Inc COGT.O :
* COGENT BIOSCIENCES APPOINTS COLE PINNOW AS CHIEF
COMMERCIAL
OFFICER
Source text for Eikon: ID:nGNX7xf2Vj
Further company coverage: COGT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cogent Biosciences
See all newsBrief: Cogent Biosciences - Enters Commercial Supply Agreement With Hovione On Sept 1, 2026 - SEC Filing
Brief: Cogent Biosciences - May Offer Up To $400 Million In Common Stock Through Guggenheim Securities
Cogent Biosciences Q2 net loss widens on higher expenses
Brief: Cogent Biosciences Q2 Net Income USD -96.405 Million
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's